DNMT1 and mucoepidermoid carcinoma: However, Shieh et al. found that mucoepidermoid carcinoma (MEC) without DNMT1 expression had longer survival rates than MEC patients with DNMT1 immunoreactivity (mean 71.9 and 31.9 months, respectively) [35].